A Thy-1–negative immunofibroblast population emerges as a key determinant of fibrotic outcomes to biomaterials

Authors: Daniel Abebayehu, Blaise N. Pfaff, Grace C. Bingham, Andrew E. Miller, Mathew Kibet, Surabhi Ghatti, Donald R. Griffin, Thomas H. Barker

Published: 2024-06-14

DOI: 10.1126/sciadv.adf2675

Source: Full article


Abstract

Fibrosis-associated fibroblasts have been identified across various fibrotic disorders, but not in the context of biomaterials, fibrotic encapsulation, and the foreign body response. In other fibrotic disorders, a fibroblast subpopulation defined by Thy-1 loss is strongly correlated with fibrosis yet we do not know what promotes Thy-1 loss. We have previously shown that Thy-1 is an integrin regulator enabling normal fibroblast mechanosensing, and here, leveraging nonfibrotic microporous annealed particle (MAP) hydrogels versus classical fibrotic bulk hydrogels, we demonstrate that